Co-trimoxazole: kinetic differences and the route of administration.
作者信息
Lazaro A, Badia A
出版信息
J Antimicrob Chemother. 1977 Sep;3(5):528-9. doi: 10.1093/jac/3.5.528.
PMID:903337
Abstract
摘要
相似文献
1
Co-trimoxazole: kinetic differences and the route of administration.
J Antimicrob Chemother. 1977 Sep;3(5):528-9. doi: 10.1093/jac/3.5.528.
2
Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).复方新诺明（甲氧苄啶-磺胺甲恶唑）的临床药代动力学
Clin Pharmacokinet. 1980 Sep-Oct;5(5):405-23. doi: 10.2165/00003088-198005050-00001.
3
Concentrations of trimethoprim and sulphamethoxazole in the human prostate gland after intramuscular injection.
Br J Urol. 1982 Oct;54(5):550-1. doi: 10.1111/j.1464-410x.1982.tb13588.x.
4
[Clinical pharmacology of co-trimoxazole (biseptol)].
Postepy Hig Med Dosw. 1983 Sep-Dec;37(5-6):537-60.
5
6
Data on the pharmacokinetics of sulphamethoxazole and trimethoprim in buffalo calves.
Zentralbl Veterinarmed A. 1984 Feb;31(1):25-30. doi: 10.1111/j.1439-0442.1984.tb01259.x.
7
Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole.甲氧苄啶、磺胺甲恶唑及甲氧苄啶-磺胺甲恶唑的吸收与尿排泄：正常年轻成年人单剂量用药结果及甲氧苄啶-磺胺甲恶唑治疗期间的初步观察
J Infect Dis. 1973 Nov;128:Suppl:584-99 p. doi: 10.1093/infdis/128.supplement_3.s584.
8
[Pharmacokinetic consequences of the mode of administration of cotrimoxazole in humans].[复方新诺明在人体内给药方式的药代动力学后果]
Rev Med Liege. 1975 Feb 15;30(4):103-9.
9
Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man.甲氧苄啶-磺胺甲恶唑在人体中的药代动力学特征。
J Infect Dis. 1973 Nov;128:Suppl:547-55 p. doi: 10.1093/infdis/128.supplement_3.s547.
10
The Pharmacokinetic profile of co-trimoxazole.
Scand J Infect Dis Suppl. 1976(8):42-9.
Zotero 插件